After thinking he just had a stubborn sinus infection that wouldn't go away, Brian McNamara was told he had an ultra-rare ...
Joint Task Force to Combat Anti-Semitism will review $256 million in contracts between the US government and Harvard. It is ...
Most women with breast cancer who paused endocrine therapy to get pregnant did not restart treatment after having a child, ...
Keegan Reilly is running not only in memory of his boss’ wife, but also for his grandmother, who is currently batting ...
Health and Me on MSN15h
FDA Approves Cabozantinib For Neuroendocrine TumorsThe approval came on the bases of the results from the phase 3 CABINET study. The study compared cabozantinib to a placebo in ...
SIGN UP TO CONTINUEPrint Subscriber? Sign Up for Full Access!Please sign up for as low as 36 cents per day to continue ...
Revolution Medicines Poster Presentations: Adaptive Immunity in Tumors / Oncogenic Pathway-Mediated Regulation of Inflammation and Tumor Immunity April 29; 3:25 p.m. – 3:40 p.m. CST ...
Three Florida men, united under a common goal of helping advance cancer research, will be running the iconic 129th Boston ...
The Donald Trump administration has threatened Harvard with a cut of $9 billion in federal grants and contracts. The ...
Oncologists share how to prioritize yourself while undergoing the difficult treatment, and real women share how positive ...
But if a lawmaker happens to lead a nonprofit — as is the case for a handful of lawmakers on Beacon Hill — lobbyists and ...
ReAlta Life Sciences, Inc. ("ReAlta" or the "Company"), a clinical-stage biopharmaceutical company dedicated to saving lives by rebalancing the inflammatory response to address rare and acute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback